Latest Remuneration News

Gullewa Limited reported a solid cash balance of A$8.1 million at the end of June 2025, supported by positive operating cash flow despite ongoing investment in exploration and corporate activities.

First Lithium Limited is on the cusp of securing critical mining license renewals in Mali and anticipates releasing its maiden Mineral Resource Estimate this quarter, while managing funding and exploration cost pressures.

Great Western Exploration Limited reported a steady cash position of A$2.7 million at the end of June 2025, maintaining sufficient funding for upcoming quarters despite ongoing exploration expenditures.

Piche Resources has appointed Karilyn Farmer as Managing Director, signaling a strategic push for its gold and uranium assets as founder Stephen Mann retires.

Hamelin Gold Limited has progressed key drilling programs in Western Australia’s premier gold provinces, backed by a recent $2.8 million capital raise that leaves it well-funded for ongoing exploration.

Vanadium Resources Limited has secured a binding two-year offtake agreement for vanadium-rich magnetite ore and raised A$1.2 million, advancing its near-term production plans at the Steelpoortdrift project.

Bubs Australia has appointed Joe Coote as its new CEO, bringing extensive international FMCG and dairy leadership to spearhead its global growth ambitions in infant nutrition.

Adrad Holdings has appointed Paul Proctor as interim CEO following Kevin Boyle's resignation, while maintaining a steady earnings forecast for FY25.

Australasian Metals Limited has reported encouraging progress at its Queensland gold and bauxite projects, highlighted by promising gold assays and elevated gallium grades, while maintaining a solid cash position of $3 million with no debt.

ClearVue Technologies has appointed Douglas Hunt as its permanent Global CEO, unveiling a refreshed leadership team focused on scaling sales, manufacturing, and product innovation. The new executives have agreed to sub-market pay until the share price hits 35 cents, signaling strong alignment with shareholder interests.

NeuroScientific Biopharmaceuticals has appointed Nathan Smith as CEO, leveraging his deep cell therapy expertise to accelerate clinical development and commercialisation of its StemSmart technology.

NEXION Group has completed the sale of its data centre subsidiary to Carrier Connect for AUD 2.5 million, marking a strategic shift to sharpen its focus on core network and AI software businesses.